Symptom clusters in ovarian cancer patients with chemotherapy after surgery: A longitudinal survey

Cancer Nursing

Volumn 39, Issue 2, 2016, Pages 106-116

  Huang, Juan ^a   Gu, Liyan ^a   Zhang, Lingjuan ^a   Lu, Xiaoying ^a   Zhuang, Wei ^b   Yang, Yan ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai First Maternity and Infant Health Hospital   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemotherapy; Memorial symptom assessment scale; Ovarian cancer; Symptom cluster

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; VINCRISTINE;

ADULT; AGED; ARTICLE; BODY IMAGE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER SURGERY; CHINESE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEMORIAL SYMPTOM ASSESSMENT SCALE; MENOPAUSAL SYNDROME; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; SYMPTOM; SYMPTOM ASSESSMENT; ADJUVANT CHEMOTHERAPY; CHINA; CLUSTER ANALYSIS; MIDDLE AGED; NURSING; OVARIAN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHINA; CLUSTER ANALYSIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OVARIAN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959373900     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0000000000000252     Document Type: Article

References (54)

1. National Cancer Center. Chinese Cancer Registry Annual Report 2011. China: Military Medical Science Press; 2011:72-73.
2. Wilmoth MC, Hatmaker-Flanigan E, LaLoggia V, Nixon T. Ovarian cancer survivors: qualitative analysis of the symptom of sexuality. Oncol Nurs Forum. 2011;38(6):699-708.
3. Phillips KM, Faul LA, Small BJ, Jacobsen PB, Apte SM, Jim HS. Comparing the retrospective reports of fatigue using the fatigue symptom index with daily diary ratings in women receiving chemotherapy for gynecologic cancer. J Pain Symptom Manage. 2013;46(2):282-288.
4. Engelen MJA, Snel BJ, Schaapueld M, et al. Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer. Eur J Cancer. 2009;45(7):1193-1200.
5. Hipkins J, Whitworth M, Tarrier N, Jayson G. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. Br J Health Psychol. 2004;9(pt 4):569-581.
6. Lenz E, Pugh L, Milliagan R, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19(3):14-27.
7. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001; 28(3):465-470.
8. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;32: 17-21.
9. Kim H, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28(4):270-282, 283-284.
10. Woods NF, Cray L. Symptom clusters and quality of life. Menopause. 2013;20(1):5-7.
11. Fox SW, Lyon DE. Symptom clusters and quality of life in survivors of lung cancer. Oncol Nurs Forum. 2006;33(5):931-936.
12. Miaskowski C. Symptom clusters: establishing the link between clinical practice and symptom management research. Support Care Cancer. 2006; 14(8):792-794.
13. Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manag. 2006;31(1):85-95.
14. Cella D, Paul D, Yount S, et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest. 2003;21(4): 526-535.
15. Skerman HM, Yates PM, Battistutta D. Cancer-related symptom clusters for symptom management in outpatients after commencing adjuvant chemotherapy, at 6 months, and 12 months. Support Care Cancer. 2012;20(1): 95-105.
16. Yeh C, Chiang Y, Chien L, Lin L, Yang C, Chuang H. Symptom clustering in older Taiwanese children with cancer. Oncol Nurs Forum. 2008;35(2): 273-281.
17. Skerman HM, Yates PM, Battistutta D. Identification of cancer-related symptom clusters: an empirical comparison of exploratory factor analysis methods. J Pain Symptom Manag. 2012;44(1):10-22.
18. Penson RT, Wenzel LB, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1): S247-S257.
19. Luckett T, King M, Butow P, Friedlander M, Paris T. Assessing healthrelated quality of life in gynecologic oncology a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer. 2010;20(4):664-684.
20. Dahl L, Wittrup I, Ggemose UV, Petersen LK, Blaakaer J. Life after gynecologic cancer-a review of patients quality of life, needs, and preferences in regard to follow-up. Int J Gynecol Cancer. 2013;23(2):227-234.
21. Hersch J, Juraskova I, Price M, Mullan B. Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review. Psycho-Oncology. 2009;18(8):795-810.
22. Zhao H, Kanda K, Liu S, Mao X. Evaluation of quality of life in Chinese patients with gynaecological cancer: assessments by patients and nurses. Int J Nurs Pract. 2003;9(1):40-48.
23. Lopez V, Copp G, Brunton L, Molassiotis A. Symptom experience in patients with gynecological cancers: the development of symptom clusters through patient narratives. J Support Oncol. 2011;9(2):64-71.
24. Wilmoth M, Hester C, Laboy S. Symptom cluster identification in ovarian cancer patients: a pilot study. Psycho-oncology. 2007;16S(3):S69.
25. Fox SW, Lyon D. Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007;30(5):354-361.
26. Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139-M144.
27. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326-1336.
28. Cheng KK, Wong EM, Ling WM, Chan CW, Thompson DR. Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the Memorial Symptom Assessment Scale. J Pain Symptom Manage. 2009;37(1):44-57.
29. Kim H, Abraham I, Malone PS. Analytical methods and issues for symptomcluster research in oncology. Curr Opin Support Palliat Care. 2013;7(1): 45-53.
30. Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39: 31-36.
31. Kim E, Jahan T, Aouizerat BE, et al. Changes in symptom clusters in patients undergoing radiation therapy. Support Care Cancer. 2009;17(11): 1383-1391.
32. Kirkova J, Walsh D, Aktas A, Davis MP. Cancer symptom clusters: old concept but new data. Am J Hosp Palliat Med. 2010;27(4):282-288.
33. Webb PM, Purdie DM, Grover S, Jordan S, Dick M, Green AC. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol. 2004;92(1):232-239.
34. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol. 2001;98(2):212-217.
35. Bankhead CR, Collins C, Stokes-Lampard H, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG Int J Obstet Gynecol. 2008;115(8):1008-1014.
36. Kim H, Barsevick AM, Tulman L, McDermott PA. Treatment-related symptom clusters in breast cancer: a secondary analysis. J Pain Symptom Manag. 2008;36(5):468-479.
37. Chen M, Lin C. Cancer symptom clusters: a validation study. J Pain Symptom Manag. 2007;34(6):590-599.
38. Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14(8):831-836.
39. Andreyev HJN. A physiological approach to modernize the management of cancer chemotherapy-induced gastrointestinal toxicity. Curr Opin Support Palliat Care. 2010;4(1):19-25.
40. Meraner V, Gamper E, Grahmann A, et al. Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer. 2012;12:77.
41. Stewart DE, Wong F, Duff S, Melancon CH, Cheung AM. "What doesn't kill youmakes you stronger": an ovarian cancer survivor survey. Gynecol Oncol. 2001;83(3):537-542.
42. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78(3 Pt 1):302-308.
43. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404-2411.
44. Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31(2):202-212.
45. Kim H, Barsevick AM, Tulman L. Predictors of the intensity of symptoms in a cluster in patients with breast cancer. J Nurs Scholarship. 2009;41(2): 158-165.
46. Molassiotis A, Wengstrom Y, Kearney N. Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Symptom Manag. 2010; 39(5):847-858.
47. Micha JP, Goldstein BH, Mattison JA, et al. Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. Gynecol Oncol. 2005; 96(1):132-135.
48. Roland KB, Rodriguez JL, Patterson JR, Trivers KF. A literature review of the social and psychological needs of ovarian cancer survivors. Psycho-oncology. 2013;22(11):2408-2418.
49. Otis-Green S, Ferrell B, Sun V, Spolum M, Morgan R, Macdonald D. Feasibility of an ovarian cancer quality-of-life psychoeducational intervention. J Cancer Educ. 2008;23(4):214-221.
50. von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol. 2006;103(1):120-126.
51. Ferrell B, Smith S, Cullinane C, Melancon C. Symptom concerns of women with ovarian cancer. J Pain Symptom Manage. 2003;25(6):528-538.
52. von Gruenigen VE, Huang HQ, Gil KM, et al. A comparison of quality-oflife domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study. J Pain Symptom Manage. 2010;39(5):839-846.
53. Parker PA, Kudelka A, Basen-Engquist K, Kavanagh J, de Moor J, Cohen L. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. Gynecol Oncol. 2006;100(3):495-500.
54. Miller M, Kearney N. Chemotherapy-related nausea and vomiting-past reflections, present practice and future management. Eur J Cancer Care. 2004;13(1):71-81.